Eventide Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-507,418
Closed -$165M 173
2024
Q1
$165M Buy
507,418
+1,198
+0.2% +$294K 2.59% 3
2023
Q4
$96.5M Buy
506,220
+150,503
+42% +$28.4M 1.57% 17
2023
Q3
$70.8M Buy
355,717
+113,260
+47% +$26.8M 1.27% 27
2023
Q2
$69.2M Buy
242,457
+582
+0.2% +$162K 1.17% 32
2023
Q1
$52.4M Buy
241,875
+202,175
+509% +$39.4M 0.96% 34
2022
Q4
$8.16M Hold
39,700
0.16% 115
2022
Q3
$11M Buy
39,700
+16,100
+68% +$4.09M 0.22% 103
2022
Q2
$4.51M Buy
+23,600
New +$4.17M 0.1% 121

Other funds holding SWAV

Eventide Asset Management's SWAV Position: Q2 2024 in Review

Eventide Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 507,418 shares — an estimated $165M sold.

Eventide Asset Management first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $165M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Eventide Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Eventide Asset Management sold 507,418 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $165M.
  • Eventide Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Eventide Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $165M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Eventide Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.